Skip to main content
Clinical Trials/NCT03613948
NCT03613948CompletedNot Applicable

Study on the Effects of Mutations Under Inherited Retinal Disease in Korean

Gangnam Severance Hospital1 site in 1 country280 target enrollmentStarted: April 10, 2018Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
280
Locations
1
Primary Endpoint
Diagnostic rate of whole exome sequencing (n=265) in Koreans with inherited retinal disease

Study Overview

Brief Summary

To develop comprehensive genetic maps of inherited retinal diseases in Korean

  • Establishment of comprehensive genetic database in Koreans with inherited retinal diseases including frequently mutated genes, genotype-phenotype correlations, and visual prognosis."

Detailed Description

Group/ Cohort Label : Subject with age between 6 months and 65 years who have not receive molecular genetic testing Group / Cohort Description : Consecutive subjects with inherited retinal disease who are willing to do genetic testing using whole exome sequencing (n=265) and whole genome sequencing (n=15) and agree to informed consent of the study

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
4 Months to 75 Years (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Inherited retinal disease
  • Age between 4 months and 75 years
  • Subject who has clinically confirmed visual impairment including night blindness or photophobia. Subject should meet one of the following criteria
  • pigmentary retinopathy in both eyes
  • reduced response in photopic or scotopic electroretinogram in both eyes
  • photoreceptor degeneration in optical coherence tomography in both eyes

Exclusion Criteria

  • unilateral retinal disease
  • Subject who had previously confirmed genetic testing
  • Age less than 4 months or more than 75 years
  • When congenital infection or trauma are suspicious for the cause of retinal disease
  • When age-related macular degeneration, myopic degeneration, autoimmune origin are suspicious for the cause of retinal disease
  • No visual impairment or normal electroretinogram (e.g., benign fleck)
  • Illiterate subject who can not understand informed consent
  • Foreigners

Outcomes

Primary Outcomes

Diagnostic rate of whole exome sequencing (n=265) in Koreans with inherited retinal disease

Time Frame: 3 years (until December 31, 2020)

patients were grouped in 1) probable molecular diagnosis: patients with pathogenic or likely pathogenic disease-associated variant(s), 2) possible molecular diagnosis: patients with 2 heterozygous mutations without segregation analysis, or patients harboring a single pathogenic or likely pathogenic disease-associated variant in a gene linked with recessive traits, provided the patient phenotype matches the known spectrum of clinical features for this gene, 3) unsolved: all other patients for which no pathogenic or likely pathogenic disease-associated variants were detected.

Secondary Outcomes

  • Diagnostic rate of whole genome sequencing (n=15) in Koreans with inherited retinal disease(3 years (until December 31, 2020))

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Jinu Han

Associate Professor

Gangnam Severance Hospital

Study Sites (1)

Loading locations...

Similar Trials

Study on the Effects of Mutations Under... | Clinical Trial